←Back to Expert Scholars
Translational Medicine / 转化医学Ki67 & Proliferation
Charles Geyer
MD
🏢NSABP Foundation / University of Pittsburgh🌐USA
Associate Director for Clinical Investigation
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Charles Geyer is a senior breast cancer trialist leading NSABP adjuvant studies for decades. He has contributed to pivotal trials that incorporated Ki67 assessment for risk stratification. His work continues to influence adjuvant chemotherapy and HER2-directed therapy decisions.
Share:
🧪Research Fields 研究领域
Adjuvant trials
NSABP cooperative group
HER2 biology
Ki67 in risk stratification
Neoadjuvant therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Charles Geyer 的研究动态
Follow Charles Geyer's research updates
留下邮箱，当我们发布与 Charles Geyer（NSABP Foundation / University of Pittsburgh）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment